Life Sciences becomes a sister company to Google, which includes the search engine, Gmail, Maps, Android and other familiar offerings.

“It’s a huge undertaking, and I am delighted to announce that the life sciences team is now ready to graduate from our X lab and become a standalone Alphabet company, with Andy Conrad as CEO“, Brin said.

Changing the reporting structure could give Life Sciences more autonomy while providing Alphabet, nee Google, executives a clearer picture of the division’s spending.

For the aforementioned smart contact lens, Google and pharma titan Novartis announced in July 2014 that they were team up on the effort; one aim of the technology is to measure blood sugar levels using tear fluid. The newly formed company will employ programmers along with staff skilled in optics and oncology. They will collaborate with other life sciences organizations to advance new technologies from the R&D stage to clinical testing and revolutionize the manner diseases are sensed, managed and prevented. The next big question is how Alphabet actually turns all these new companies in revenue drivers rather than being reliant on Google.

Page had claimed: “This newer Google is a bit slimmed down, with the companies that are pretty far afield of our main internet products contained in Alphabet instead”.

BMW on Tuesday said it was looking into whether Google infringed any trademark rights after the Silicon Valley-based group set up a new company called Alphabet, which is also the name of a BMW subsidiary.

Andy Conrad, head of Google Life Sciences, will be CEO of the new life sciences group, Brin wrote.

Google X spins off its Life Sciences division. Google X is well known as the experimentation division of Google.

“Three years ago we embarked on a project to put computing inside a contact lens – an immensely challenging technical problem with an important application to health”, he said.

Google Life Sciences also had a similar device in the works, such as glucose monitoring patches that will be both high-tech and low-priced mostly for patients suffering from type 1 diabetes.